OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 68 filers reported holding OCULAR THERAPEUTIX INC in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $69 | -100.0% | 13,383 | +5.9% | 0.01% | -70.6% |
| Q2 2021 | $179,000 | -31.7% | 12,641 | -20.7% | 0.02% | -10.5% |
| Q1 2021 | $262,000 | +77.0% | 15,938 | -18.1% | 0.02% | -24.0% |
| Q3 2020 | $148,000 | -21.7% | 19,459 | -59.3% | 0.02% | +38.9% |
| Q4 2019 | $189,000 | +509.7% | 47,820 | +374.2% | 0.02% | +800.0% |
| Q3 2019 | $31,000 | -77.9% | 10,085 | -51.2% | 0.00% | -66.7% |
| Q2 2018 | $140,000 | +6.9% | 20,672 | +2.6% | 0.01% | -14.3% |
| Q1 2018 | $131,000 | -53.2% | 20,139 | -68.0% | 0.01% | -53.3% |
| Q4 2017 | $280,000 | – | 63,020 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
| Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
| DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
| Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
| GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
| Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
| Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
| Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
| Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |